Industry context
Zhengye Biotechnology [ZYBT]
Zuletzt aktualisiert 25 Jun 2026 @ 16:00 (Exchange is closed)
Letzter Kurs: $0.761
-1.46%
-5.31
GaG Algo Score™
v1.0
Kurz
-5.31
Mittel
-6.32
Lang
-6.25
Linie
Pivot-Daten
Pivot-Statistik
| Kennzahl | Durchschnitt | Median | Std.-Abw. |
|---|---|---|---|
| Gewinn % | 15.03% | 15.03% | 1.50% |
| Verlust % | -24.64% | -24.64% | 4.04% |
| Dauer | 14.5d | 15d | 5.4d |
| Gefundene Pivots gesamt | 5 |
| Gewinn-/Verlustphasen | 4 (2 Gewinn / 2 Verlust) |
| Letzter Pivot | Top @ $0.90 am 2026-06-10 |
| Änderung seit letztem Pivot | $-0.14 (-15.47%) |
Nächste Pivot-Prognose Letzter Kurs: $0.76
| Erwarteter nächster Typ | Bottom |
| Erwarteter Preis (Durchschn.) | $0.68 |
| Erwarteter Preis (Median) | $0.68 |
| Erwarteter Preisbereich (~68%) | $0.64 - $0.71 |
| Änderung zum Durchschnittsziel | $-0.08 (-10.85%) |
| Erwartetes Datum (Durchschn.) | 2026-06-24 |
| Erwarteter Datumsbereich (~68%) | 2026-06-19 - 2026-06-29 |
| Basis | Based on 2 historical losses (Avg: -24.64%, Median: -24.64%, StdDev of Abs: 4.04%) and duration (Avg: 14.5 days, StdDev: 5.4 days) |
| Hinweis | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Zhengye Biotechnology lost modestly, down -1.46%.
Zhengye Biotechnology (ZYBT) stock price retreated on Thursday after the stock fell $-0.0113 (-1.46%) from the previous session on extremely light volume. The stock fell slightly more than the NASDAQ which was down -0.46%. Yesterday's trading volume was 28 243 shares, worth about $21 496. This represents 3 439 shares more than the day before. Volume was below the 10-day average of 308 249 shares.
Zhengye Biotechnology signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Strong Bearish Consensus: A significant wave of negative pressure is evident across all time horizons. Technical indicators are decisively bearish in the short-term (18/30, net -56.7%), medium-term (18/30, net -56.7%), and long-term (18/30, net -56.7%), signaling a robust and sustained downtrend.
Zhengye Biotechnology Support & Resistance Levels
The stock is trading above the closest support level at $0.760. approximately $0.00110 (0.14%) away. This suggests it is currently acting as a floor, pushing down towards support.The sup dis das support s10.76 -
Zhengye Biotechnology Evaluation
- Kurz Score: -5.31
- Mittel Score: -6.32
- Lang Score: -6.25
Ownership flow
GetAGraph InsiderPower
Transactions
17
Buy power
0
Sell power
0
Reliability
64/100
Buy / sell
0.00
Hist. corr.
0.00
Latest signal
-
Officer 9
Director 8
2026-06-25
Han Zhenfa Director
Other
2026-06-25
Cheng Yuhong (nmn) Officer
Other
2026-06-25
Song Songlin Officer
Other
2026-06-25
Wang Ping (nmn) Officer
Other
2026-06-25
Jiang Ping (piji) Director
Other
2026-03-24
Hu Qiyi Director
Other
Relationship map
Correlation snapshot
Most
ZYXI 0.85Least
Positioning pressure
Short interest pressure
Short interest
0.06%
Of outstanding shares
Short float
0.67%
Of tradable float
Days to cover
4.18
Short interest divided by average volume
Squeeze probability
1.60%
-12.58% change
Short interest is worth monitoring, but the setup is not extreme.
Updated 2026-05-29News flow
Latest company news
Market coverage
globenewswire.com Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency Jun 4, 2026 globenewswire.com Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency Jun 4, 2026 prnewswire.com Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results Apr 28, 2026 globenewswire.com Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure Apr 6, 2026Company releases
Company context
Company profile
Börse:
NASDAQ
Sektor:
Healthcare
Branche:
Drug Manufacturers Specialty Generic
Currency
USD
Zhengye Biotechnology Holding Limited specializes in the creation manufacturing and commercialization of animal health immunizations The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals including swine bovines goats ovines and poultry Additionally its product range encompasses inoculations for canines Beyond its domestic reach the firm also distributes its offerings to international markets notably exporting to Vietnam Pakistan and Egypt Established in 2004 this enterprise bases its principal operations in Jilin China and operates as a subsidiary entity of Securingium Holding Limited
Navigation